Wall Street Experts
ver. ZuMIgo(08/25)
Abeona Therapeutics Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 3
EBIT TTM (mln): -68
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19 |
20 |
21 |
22 |
23 |
24 |
25 |
Rok finansowy |
1999 |
2000 |
2001 |
2002 |
2003 |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
1 |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
4 |
2 |
1 |
1 |
1 |
1 |
3 |
0 |
10 |
3 |
1 |
4 |
0 |
Przychód Δ r/r |
0.0% |
613.3% |
127.1% |
372.0% |
12.9% |
-57.6% |
-100.0% |
0.0% |
inf% |
410.5% |
21.0% |
36.6% |
284.2% |
138.3% |
-53.6% |
-54.7% |
12.4% |
-14.5% |
-5.8% |
258.2% |
-100.0% |
inf% |
-70.0% |
-52.9% |
147.5% |
-100.0% |
Marża brutto |
100.0% |
100.0% |
100.0% |
90.7% |
78.6% |
56.5% |
0.0% |
0.0% |
100.0% |
100.0% |
100.0% |
70.9% |
34.2% |
93.9% |
93.9% |
100.0% |
100.0% |
100.0% |
100.0% |
100.0% |
-inf% |
-201.4% |
-48.8% |
68.2% |
8.6% |
0.0% |
EBIT (mln) |
-3 |
-6 |
-6 |
-9 |
-8 |
-9 |
-10 |
-5 |
-7 |
-17 |
-10 |
-8 |
-8 |
-4 |
-4 |
-3 |
-19 |
-24 |
-28 |
-58 |
-77 |
-81 |
-90 |
-45 |
-48 |
-64 |
EBIT Δ r/r |
0.0% |
80.9% |
4.1% |
37.9% |
-5.6% |
10.5% |
6.0% |
-46.2% |
33.3% |
145.1% |
-42.8% |
-19.8% |
1.5% |
-45.2% |
-11.9% |
-17.7% |
492.3% |
28.8% |
16.6% |
109.0% |
32.5% |
5.6% |
10.3% |
-49.6% |
6.5% |
33.2% |
EBIT (%) |
-22326.7% |
-5661.7% |
-2595.9% |
-758.5% |
-634.2% |
-1653.7% |
0.0% |
0.0% |
-12105.3% |
-5812.7% |
-2748.9% |
-1612.7% |
-426.2% |
-98.0% |
-186.3% |
-338.5% |
-1783.3% |
-2686.3% |
-3325.7% |
-1940.2% |
0.0% |
-814.2% |
-2994.5% |
-3200.6% |
-1377.1% |
nan |
Koszty finansowe (mln) |
0 |
0 |
1 |
1 |
1 |
1 |
2 |
7 |
4 |
0 |
1 |
1 |
1 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
0 |
4 |
4 |
1 |
0 |
-4 |
EBITDA (mln) |
-3 |
-6 |
-6 |
-8 |
-7 |
-8 |
-6 |
3 |
7 |
-16 |
-2 |
-6 |
-6 |
-4 |
-4 |
-3 |
-14 |
-21 |
-27 |
-54 |
-67 |
-43 |
-54 |
-45 |
-45 |
-64 |
EBITDA(%) |
-20426.7% |
-5216.8% |
-2337.9% |
-698.7% |
-564.9% |
-1457.7% |
0.0% |
0.0% |
12847.4% |
-5664.6% |
-642.9% |
-1309.8% |
-341.4% |
-83.0% |
-173.8% |
-332.4% |
-1343.2% |
-2366.9% |
-3174.4% |
-1811.2% |
0.0% |
-426.2% |
-1801.7% |
-3160.2% |
-1285.8% |
nan |
Podatek (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
-4 |
-0 |
-0 |
0 |
8 |
-0 |
0 |
1 |
0 |
1 |
4 |
2 |
1 |
2 |
0 |
4 |
4 |
-8 |
0 |
0 |
Zysk Netto (mln) |
-3 |
-5 |
-6 |
-9 |
-7 |
-10 |
-2 |
-13 |
-22 |
-17 |
-17 |
-8 |
-3 |
-11 |
4 |
-27 |
-15 |
-22 |
-27 |
-57 |
-77 |
-88 |
-89 |
-32 |
-54 |
-64 |
Zysk netto Δ r/r |
0.0% |
64.1% |
11.0% |
55.7% |
-26.1% |
47.6% |
-83.4% |
657.3% |
69.8% |
-21.2% |
0.7% |
-56.5% |
-66.4% |
316.0% |
-142.2% |
-701.9% |
-45.8% |
50.6% |
24.9% |
107.4% |
35.3% |
15.2% |
0.3% |
-64.1% |
70.4% |
17.6% |
Zysk netto (%) |
-22053.3% |
-5072.9% |
-2480.2% |
-818.1% |
-535.5% |
-1864.8% |
0.0% |
0.0% |
-38343.9% |
-5915.8% |
-4926.1% |
-1566.9% |
-137.0% |
-239.1% |
217.9% |
-2894.9% |
-1396.7% |
-2460.4% |
-3263.9% |
-1890.3% |
0.0% |
-883.5% |
-2953.5% |
-2249.6% |
-1548.2% |
nan |
EPS |
-3396.3 |
-3073.61 |
-2930.0 |
-4477.1 |
-3268.14 |
-4221.86 |
-656.62 |
-4557.17 |
-7693.07 |
-2575.94 |
-1834.14 |
-602.67 |
-158.39 |
-544.49 |
76.75 |
-344.56 |
-13.16 |
-16.0 |
-16.4 |
-29.81 |
-38.07 |
-23.84 |
-22.5 |
-4.05 |
-2.53 |
-1.55 |
EPS (rozwodnione) |
-3396.3 |
-3073.61 |
-2930.0 |
-4477.1 |
-3268.14 |
-4221.86 |
-656.62 |
-4557.17 |
-7693.07 |
-2575.94 |
-1834.14 |
-602.67 |
-158.39 |
-544.49 |
76.0 |
-344.56 |
-13.16 |
-16.0 |
-16.4 |
-29.81 |
-38.07 |
-23.84 |
-22.5 |
-4.05 |
-2.53 |
-1.55 |
Ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
2 |
2 |
4 |
4 |
8 |
21 |
41 |
Ważona ilośc akcji (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
2 |
2 |
2 |
4 |
4 |
8 |
21 |
41 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |